178 related articles for article (PubMed ID: 22936314)
1. Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.
Sridar C; Kenaan C; Hollenberg PF
Drug Metab Dispos; 2012 Dec; 40(12):2256-66. PubMed ID: 22936314
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of mifepristone [RU486; 17beta-hydroxy-11beta-(4-dimethylaminophenyl)-17alpha-(1-propynyl)-estra-4,9-dien-3-one] by mammalian cytochromes P450 and the mechanism-based inactivation of human CYP2B6.
Lin HL; Zhang H; Hollenberg PF
J Pharmacol Exp Ther; 2009 Apr; 329(1):26-37. PubMed ID: 19168709
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
[TBL] [Abstract][Full Text] [Related]
4. Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6.
Sridar C; Kent UM; Notley LM; Gillam EM; Hollenberg PF
J Pharmacol Exp Ther; 2002 Jun; 301(3):945-52. PubMed ID: 12023523
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.
Zhang H; Sridar C; Kenaan C; Amunugama H; Ballou DP; Hollenberg PF
J Pharmacol Exp Ther; 2011 Sep; 338(3):803-9. PubMed ID: 21659470
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme.
Amunugama HT; Zhang H; Hollenberg PF
Drug Metab Dispos; 2012 Sep; 40(9):1765-70. PubMed ID: 22685215
[TBL] [Abstract][Full Text] [Related]
8. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of N,N',N"-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the inactivation of both isoforms by two distinct mechanisms.
Harleton E; Webster M; Bumpus NN; Kent UM; Rae JM; Hollenberg PF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1011-9. PubMed ID: 15121764
[TBL] [Abstract][Full Text] [Related]
10. Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene.
Lin HL; Zhang H; Pratt-Hyatt MJ; Hollenberg PF
Drug Metab Dispos; 2011 Dec; 39(12):2431-9. PubMed ID: 21930824
[TBL] [Abstract][Full Text] [Related]
11. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
[TBL] [Abstract][Full Text] [Related]
12. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.
Hesse LM; von Moltke LL; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2001 Feb; 29(2):100-2. PubMed ID: 11159797
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of human cytochrome P450 2B6 by clopidogrel: involvement of both covalent modification of cysteinyl residue 475 and loss of heme.
Zhang H; Amunugama H; Ney S; Cooper N; Hollenberg PF
Mol Pharmacol; 2011 Nov; 80(5):839-47. PubMed ID: 21862689
[TBL] [Abstract][Full Text] [Related]
14. The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir.
Lin HL; D'Agostino J; Kenaan C; Calinski D; Hollenberg PF
Drug Metab Dispos; 2013 Oct; 41(10):1813-24. PubMed ID: 23886699
[TBL] [Abstract][Full Text] [Related]
15. The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine.
Jushchyshyn MI; Kent UM; Hollenberg PF
Drug Metab Dispos; 2003 Jan; 31(1):46-52. PubMed ID: 12485952
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human CYP2B6 by N,N',N''-triethylenethiophosphoramide is irreversible and mechanism-based.
Richter T; Schwab M; Eichelbaum M; Zanger UM
Biochem Pharmacol; 2005 Feb; 69(3):517-24. PubMed ID: 15652242
[TBL] [Abstract][Full Text] [Related]
17. Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo.
Xu C; Ogburn ET; Guo Y; Desta Z
Drug Metab Dispos; 2012 Apr; 40(4):717-25. PubMed ID: 22232427
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
Turpeinen M; Nieminen R; Juntunen T; Taavitsainen P; Raunio H; Pelkonen O
Drug Metab Dispos; 2004 Jun; 32(6):626-31. PubMed ID: 15155554
[TBL] [Abstract][Full Text] [Related]
19. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine.
Richter T; Mürdter TE; Heinkele G; Pleiss J; Tatzel S; Schwab M; Eichelbaum M; Zanger UM
J Pharmacol Exp Ther; 2004 Jan; 308(1):189-97. PubMed ID: 14563790
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship and elucidation of the determinant factor(s) responsible for the mechanism-based inactivation of cytochrome P450 2B6 by substituted phenyl diaziridines.
Kobayashi Y; Sridar C; Kent UM; Puppali SG; Rimoldi JM; Zhang H; Waskell L; Hollenberg PF
Drug Metab Dispos; 2006 Dec; 34(12):2102-10. PubMed ID: 16997911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]